Ventral prostate fibrosis in the akita mouse is associated with macrophage and fibrocyte infiltration

Journal of Diabetes Research

Volumn 2014, Issue , 2014, Pages

  Lee, Sanghee ^a   Yang, Guang ^a   Mulligan, William ^a   Gipp, Jerry ^a   Bushman, Wade ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; COLLAGEN; VIMENTIN; EOSIN; HEMATOXYLIN;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELLS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROCYTE; FIBROSIS; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATE VENTRAL LOBE; PROSTATE VENTRAL LOBE FIBROSIS; T LYMPHOCYTE; ANIMAL; CHEMISTRY; CYTOLOGY; DBA MOUSE; INFLAMMATION; LOWER URINARY TRACT SYMPTOMS; METABOLISM; MONOCYTE; PATHOLOGY; PROSTATE; PROSTATIC HYPERPLASIA;

ANIMALS; COLLAGEN; EOSINE YELLOWISH-(YS); FEMALE; FIBROSIS; HEMATOXYLIN; INFLAMMATION; LOWER URINARY TRACT SYMPTOMS; MACROPHAGES; MALE; MICE; MICE, INBRED DBA; MONOCYTES; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA;

EID: 84903591953     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2014/939053     Document Type: Article

References (29)

1. Bushman W., Etiology, epidemiology, and natural history. Urologic Clinics of North America 2009 36 4 403 415 2-s2.0-70449724699 10.1016/j.ucl.2009.07.003
2. Ma J., Gharaee-Kermani M., Kunju L., Prostatic fibrosis is associated with lower urinary tract symptoms. The Journal of Urology 2012 188 4 1375 1381 10.1016/j.juro.2012.06.007
3. Bercovich E., Barabino G., Pirozzi-Farina F., Deriu M., A multivariate analysis of lower urinary tract ageing and urinary symptoms: the role of fibrosis. Archivio Italiano di Urologia, Andrologia 1999 71 5 287 292 2-s2.0-0033256277
4. Parsons J. K., Ballentine H., Partin A. W., Metabolic factors associated with benign prostatic hyperplasia. The Journal of Clinical Endocrinology & Metabolism 2006 91 7 2562 2568 10.1210/jc.2005-2799 (Pubitemid 44024618)
5. Sugimura Y., Cunha G. R., Donjacour A. A., Morphogenesis of ductal networks in the mouse prostate. Biology of Reproduction 1986 34 5 961 971 2-s2.0-0022728642
6. Zechner D., Knapp N., Bobrowski A., Radecke T., Genz B., Vollmar B., Diabetes increases pancreatic fibrosis during chronic inflammation. Experimental Biology and Medicine. In press
7. Boehm B. J., Colopy S. A., Jerde T. J., Loftus C. J., Bushman W., Acute bacterial inflammation of the mouse prostate. Prostate 2012 72 3 307 317 2-s2.0-84255212972 10.1002/pros.21433
8. Nagano J., Shimizu M., Hara T., Effects of indoleamine 2, 3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. PLoS ONE 2013 8 9 e73404 10.1371/journal.pone.0073404
9. Cox T. R., Bird D., Baker A.-M., LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Research 2013 73 6 1721 1732 10.1158/0008-5472.CAN-12-2233
10. Wynn T. A., Cellular and molecular mechanisms of fibrosis. Journal of Pathology 2008 214 2 199 210 2-s2.0-38549159026 10.1002/path.2277 (Pubitemid 351160157)
11. McKleroy W., Lee T. H., Atabai K., Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. American Journal of Physiology: Lung Cellular and Molecular Physiology 2013 304 11 L709 L721 10.1152/ajplung.00418.2012
12. Ribeiro D. L., Caldeira E. J., Cândido E. M., Manzato A. J., Taboga S. R., Cagnon V. H., Prostatic stromal microenvironment and experimental diabetes. European Journal of Histochemistry 2006 50 1 51 60 2-s2.0-33744981163
13. Ribeiro D. L., Taboga S. R., Góes R. M., Diabetes induces stromal remodelling and increase in chondroitin sulphate proteoglycans of the rat ventral prostate. International Journal of Experimental Pathology 2009 90 4 400 411 2-s2.0-68849128993 10.1111/j.1365-2613.2009.00657.x
14. Cagnon V. H. A., Camargo A. M., Rosa R. M., Fabiani R., Padovani C. R., Martinez F. E., Ultrastructural study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57BL/6J). Tissue and Cell 2000 32 4 275 283 2-s2.0-0033696437 10.1054/tice.2000.0123
15. Powers G. L., Marker P. C., Recent advances in prostate development and links to prostatic diseases. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 2013 5 2 243 256
16. Gharaee-Kermani M., Rodriguez-Nieves J. A., Mehra R., Obesity-induced diabetes and lower urinary tract fibrosis promote urinary voiding dysfunction in a mouse model. The Prostate 2013 73 10 1123 1133 10.1002/pros.22662
17. Sugimura Y., Sakurai M., Hayashi N., Yamashita A., Kawamura J., Age-related changes of the prostate gland in the senescence-accelerated mouse. The Prostate 1994 24 1 24 32 2-s2.0-0028006064 (Pubitemid 24050583)
18. Lin C. L., Cannabinoid receptor 1 disturbance of PPARgamma2 augments hyperglycemia induction of mesangial inflammation and fibrosis in renal glomeruli. Journal of Molecular Medicine. In press
19. Liu Y., Wang Y., Miao X., Inhibition of JNK by compound C66 prevents pathological changes of the aorta in STZ-induced diabetes. Journal of Cellular and Molecular Medicine 2014 10.1111/jcmm.12267
20. Hartono S. P., Knudsen B. E., Lerman L. O., Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrology 2014 15 1, article 58 10.1186/1471-2369-15-58
21. Wang Y., Zhang Z., Sun W., Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of nrf2 expression and function. Oxidative Medicine and Cellular Longevity 2014 2014 11 10.1155/2014/123963 123963
22. Cartland S. P., Erlich J. H., Kavurma M. M., TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice. PLoS ONE 2014 9 3 e92952
23. Delghingaro-Augusto V., Madad L., Chandra A., Islet inflammation, hemosiderosis, and fibrosis in intrauterine growth-restricted and high fat-fed sprague-dawley rats. The American Journal of Pathology 2014 184 5 1446 1457 10.1016/j.ajpath.2014
24. Morris S. M. Jr., Gao T., Cooper T. K., Kepka-Lenhart D., Awad A. S., Arginase-2 mediates diabetic renal injury. Diabetes 2011 60 11 3015 3022 2-s2.0-80755152815 10.2337/db11-0901
25. Chow F. Y., Nikolic-Paterson D. J., Atkins R. C., Tesch G. H., Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrology Dialysis Transplantation 2004 19 12 2987 2996 2-s2.0-11244267207 10.1093/ndt/gfh441 (Pubitemid 40057619)
26. Proctor G., Jiang T., Iwahashi M., Wang Z., Li J., Levi M., Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006 55 9 2502 2509 2-s2.0-33750580307 10.2337/db05-0603 (Pubitemid 44871150)
27. Reilkoff R. A., Bucala R., Herzog E. L., Fibrocytes: emerging effector cells in chronic inflammation. Nature Reviews Immunology 2011 11 6 427 435 2-s2.0-79957624520 10.1038/nri2990
28. Rodriguez-Nieves J. A., Macoska J. A., Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nature Reviews Urology 2013 10 9 546 550
29. Cantiello F., Cicione A., Salonia A., Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology 2013 81 5 1018 1023 10.1016/j.urology.2013.01.053